Is Sigachi Indust. overvalued or undervalued?

As of 7 August 2025, the valuation grade for Sigachi Industries has moved from fair to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued. Key ratios include a PE Ratio of 16.51, an EV to EBITDA of 12.81, and a ROCE of 12.97%.
In comparison to its peers, Sigachi's valuation metrics stand out; for instance, Sun Pharma has a much higher PE Ratio of 33.44, while Divi's Lab is even more expensive with a PE of 70.6. This positions Sigachi favorably within the pharmaceuticals and biotechnology sector, suggesting that it offers a compelling investment opportunity relative to its peers. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 34.32% compared to a 3.18% gain for the index, the current valuation reflects a strong potential for recovery and growth.